Dividends & Buybacks · Oct 22, 2026

Ping An Biomedical to consolidate shares 40-for-1 on Oct. 23, increase authorized capital

PASWPing An Biomedical Co., Ltd.

Shareholders are being asked to ratify a 40-for-one share consolidation effective October 23, 2026, and approve an increase in authorized share capital from US$312,500 to US$12.5 million. The filing also outlines conditional further consolidations ranging from 10-to-1 up to 80-to-1 if the stock price falls below specified thresholds. Ping An Biomedical Co., Ltd. operates in the biomedical and healthcare sector.